FILE:BMY/BMY-8K-20080801103322.txt.gz
EVENTS:	Other Events	Financial Statements and Exhibits
TEXT:
ITEM: Other Events
ITEM: Financial Statements and Exhibits
 
 
 
 
 
 
 
 
 
 
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( General Instruction A.2. below):
see
 
 
 
 
 
 
 
On July 31, 2008, Bristol-Myers Squibb Company ("BMS") filed a Form 8-K attaching a press release announcing its proposal to enter into an agreement to acquire ImClone Systems Incorporated ("ImClone") for $60 per share in cash. As stated in the press release, BMS conducted an investor relations conference call on July 31, 2008 at 8:30 a.m., (EDT), to discuss the proposed acquisition of ImClone. Both the audio web cast replay and a written transcript of the conference are now available on . The transcript of the conference call is attached as Exhibit 99.2 to this report and is incorporated herein by reference.
www.bms.com/ir
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 

Exhibit 99.2
 


